ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
22 announcements with these filters
Kerala Ayurveda Ltd revised its preferential issue, reducing the offer size to 6,55,000 equity shares at Rs. 190.37 each, totaling Rs. 12.47 Crore.
The board approved revising the preferential issue from 7,20,000 to 6,55,000 equity shares to Katra Holding Private Limited, totaling approximately Rs. 12.47 Crore.
Kerala Ayurveda Limited has issued the notice for its 34th Annual General Meeting, featuring four agenda items, including financial statement adoption and a preferential share issue.
Kerala Ayurveda Ltd has scheduled its 34th Annual General Meeting for September 28, 2026, via video conference. The company also filed its Annual Report for FY 2025-26.
Kerala Ayurveda Ltd approved a preferential issue of 7.20 lakh equity shares to its promoter group. The Rs. 13.71 Crore issue converts outstanding unsecured debt into equity.
Kerala Ayurveda will hold a board meeting on September 4, 2026, to discuss a preferential issue of equity shares and convene its 34th Annual General Meeting.
Kerala Ayurveda released its Q1 FY27 financial performance highlights, reporting consolidated revenue of ₹33.2 Crore and outlining its roadmap for Vision 2030 expansion.
Kerala Ayurveda Ltd granted 64,875 options under its ESOP 2023 scheme. The options have an exercise price of Rs. 10 per share.
Kerala Ayurveda Limited announced the merger of its wholly-owned subsidiary, Ayurvedagram Heritage Wellness Centre Private Limited, into itself. This restructuring aims to consolidate operations and improve efficiency.
Kerala Ayurveda Ltd reported revenue from operations of ₹33.2 Cr (+16.1% YoY) and a net loss of ₹6.8 Cr for Q1 FY27.
Kerala Ayurveda Limited will hold a board meeting on August 12, 2026, to approve unaudited financial results for the quarter ended June 30, 2026.
Kerala Ayurveda Ltd filed its quarterly shareholding pattern for the quarter ended June 30, 2026, pursuant to SEBI regulations.
Independent Director Mr. Samir Dhawan resigned from Kerala Ayurveda Limited effective June 09, 2026. He cited other professional commitments as the reason for his departure.
Kerala Ayurveda Limited updated its list of Key Managerial Personnel authorized to determine event materiality. This routine regulatory filing ensures compliance with SEBI disclosure requirements.
Kerala Ayurveda Limited appointed Mr. Binu Thomas as Company Secretary and Compliance Officer effective June 9, 2026. This strengthens the company's corporate governance and regulatory compliance functions.
Kerala Ayurveda Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The governance document was prepared by M/s. SVJS & Associates.
Kerala Ayurveda Ltd reported FY 26 revenue of ₹145.4 Crore, reflecting 22% growth excluding discontinued business. The standalone entity crossed the ₹100 Crore milestone.
Kerala Ayurveda Ltd reported revenue from operations of ₹34.7 Cr (+10.9% YoY) and a net loss of ₹9.2 Cr for Q4 FY26.
Kerala Ayurveda reported standalone annual revenue of ₹103.42 Crore for FY2026. The board also appointed internal and cost auditors during the meeting to oversee operations.
Kerala Ayurveda Limited scheduled a board meeting on May 25, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-publication.
BSE Limited rejected Kerala Ayurveda Ltd's waiver application for a ₹5.31 lakh fine. The penalty was levied for non-compliance with board composition requirements between October 2024 and June 2025. The company paid the amount under protest on March 10, 2026.
Kerala Ayurveda Ltd clarified to BSE that recent share price volatility is purely market-driven. The company confirmed it has disclosed all price-sensitive information under SEBI regulations and is not withholding any material events that could impact share behavior.